Augmedix Inc

NASDAQ:AUGX   1:54:37 PM EDT
1.12
0.00 (0.00%)
Earnings Announcements

Augmedix Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:41 GMT
Augmedix Inc (AUGX) - Augmedix Reports Third Quarter 2022 Financial Results.
Q3 Revenue Rose 40 Percent to $7.9 Million.
Cash, Cash Equivalents and Restricted Cash As of September 30, 2022, Was $27.0 Million Compared to $11.1 Million As of September 30, 2021.
Qtrly GAAP Net Loss Was $5.5 Million.
Q3 Revenue View $7.8 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $8.52 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $8.92 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.